Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver

NCT03472586 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Malignant Neoplasm in the Liver
Metastatic Uveal Melanoma
Stage IV Uveal Melanoma AJCC v7

Interventions

BIOLOGICAL: Ipilimumab
BIOLOGICAL: Nivolumab
DRUG: Embolization Therapy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]